Spinal cord simulator given green light for Japanese launchRSS Feed

22 January 2010

An innovative new spinal cord stimulation system has been given the go-ahead to be launched onto the Japanese market.

The Genesis device is geared towards offering neurostimulation for spinal cord patients, with US manufacturer St Jude Medical explaining that it is particularly useful for managing chronic back pain and other pains associated with back surgeries that have failed.

Now, the company has confirmed that the Japanese Ministry of Health, Labour and Welfare has given its approval for the system to be launched in the Asian country, with the device set to be made available to healthcare providers there within the coming weeks.

Welcoming the news, the president of the neuromodulation division at St Jude Medical, Chris Chavez, stated: "The launch of the Genesis system in Japan is a significant step in our continued international growth.

"We are excited to introduce our technology in Japan and to be able to provide a new option for physicians and patients that will help them manage the severest forms of chronic pain."

This comes soon after the Caliron Ledger reported that spinal injury patients have been benefiting from the NESS L300 system, capable of electronically stimulating damaged nerves.

Serious Law, leading spinal cord injury solicitors ADNFCR-2547-ID-19571989-ADNFCR